Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(25.0%)

Phase 3

1(25.0%)

Phase 2

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(1)

Phase 3(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00463294Phase 3Completed

Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study

Role: collaborator

NCT01458444Not ApplicableCompleted

BIPAP Vision Versus OPTIFLOW System Comparison in Acute Respiratory Failure After Cardio Thoracic Surgery

Role: collaborator

NCT01918982Unknown

Circulating Endothelial Progenitor Cells and Aortic Aneurysm

Role: lead

NCT01918969Unknown

Reference Values of Circulating Endothelial Progenitor Cells

Role: lead

NCT01227122Unknown

NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure

Role: lead

NCT00243477Phase 4Completed

MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting

Role: lead

NCT00544011Phase 2Unknown

Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Role: lead

All 7 trials loaded